You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 9, September 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Immunology
 •Immunology, Other
 •Transplantation, Other
 •Alert me on articles by topic

Outcome After Intestinal Transplantation

Results From One Center's 9-Year Experience

Douglas G. Farmer, MD; Suzanne V. McDiarmid, MD; Hasan Yersiz, MD; Galen Cortina, MD; Farin Amersi, MD; Jorge Vargas, MD; George Gershman, MD; Marvin Ament, MD; Ronald W. Busuttil, MD,PhD

Arch Surg. 2001;136:1027-1032.

Hypothesis  Outcomes after intestinal transplantation have improved during the past decade with refinements in surgical techniques as well as advances in immunosuppression and antimicrobial therapy.

Design  Retrospective analysis.

Setting  Tertiary care medical center, August 1991 through December 2000.

Patients  Adult (5) and pediatric (12) patients with intestinal failure. All developed complications from long-term total parenteral nutrition therapy. Median age was 8.6 years and median weight was 22 kg.

Interventions  Primary intestinal transplantation with (n = 14) or without (n = 3) the liver.

Main Outcome Measures  Patient and graft survival, viral infections, rejection, and nutritional autonomy.

Results  Twenty-one intestinal grafts were transplanted into the 17 recipients. All donors were cadaveric and were matched by ABO blood group and size. Patient survival at 1 and 3 years was 63% and 55%, respectively. Death-censored graft survival at 1 and 3 years was 73% and 55%, respectively. There were 1.5 acute cellular rejection episodes per graft and 3 grafts were lost to rejection. Incidences of infection with the Epstein-Barr virus and cytomegalovirus were negligible with aggressive prophylaxis and preemptive therapy. Nutritional autonomy was achieved in 69% of grafts surviving more than 30 days after intestinal transplantation.

Conclusions  Intestinal transplantation is now the standard of therapy for patients with intestinal failure and complications resulting from total parenteral nutrition. Outcomes have markedly improved since initiation of the program. Aggressive immunosuppression as well as prophylaxis and preemptive antiviral therapy have led to low incidences of acute cellular rejection, Epstein-Barr virus, and cytomegalovirus. Finally, nutritional autonomy can be achieved after successful intestinal transplantation.


From the Departments of Surgery (Drs Farmer, Yersiz, Amersi, and Busuttil); Pediatrics (Drs McDiarmid, Vargas, Gershman, and Ament); and Pathology (Dr Cortina), University of California, Los Angeles, UCLA School of Medicine, Los Angeles.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.